CUSIP 00773U108Common StockADVMCHFQ3 2025
59 filings · latest Dec 9, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Versant Venture Management, LLC | 506.8K | $2.30M |
| 4 | May 20, 2025 | Bml Investment Partners, L.P. | 13D | 15.6% | — | SEC |
| 5 | May 15, 2025 | Tcg Crossover Gp II, LLC | 13G/A | 11.0% | 1.87M | SEC |
| 6 | May 6, 2025 | Bml Investment Partners, L.P. | 13G/A | 13.8% | 2.88M | SEC |
| 7 | Feb 13, 2025 | Bml Investment Partners, L.P. | 13G/A | 11.4% | 2.37M | SEC |
| 8 | Jul 22, 2024 | Bml Investment Partners, L.P. | 13G/A | 10.1% | 2.10M | SEC |
| 9 | May 14, 2024 | Versant Ventures IV, LLC | 13D/A | 2.4% | 500.4K | SEC |
| 10 | Apr 29, 2024 | Bml Investment Partners, L.P. | 13G/A | 5.1% | 1.05M | SEC |
See the full Schedule 13D/13G history for Adverum Biotechnologies, Inc..
Unlock full history